On June 13, Aipu Corporation responded to inquiries from investors on its interactive platform. The company announced its plan to establish a laboratory in Guangdong province this year to carry out research and exploration on the upgrading of e-cigarette atomization technology and various application scenarios, as well as the expansion of sales and services to e-cigarette enterprises. The company also addressed the use of fragrance in tobacco products.
Question: Can you provide an update on the company's progress in cigarette flavors? Have there been any developments in the e-cigarette industry?
Dear investors, we plan to establish a laboratory in Guangdong province this year to conduct research and explore various application scenarios for e-cigarette aerosols. This will include upgrading the relevant technology and expanding sales and services to e-cigarette companies through the use of tobacco flavorings. Thank you for your attention.
Interactive Platform | Image Source: Shanghai Securities Exchange Interactive
According to reports, Aipu Flavor & Fragrance Group Co. Ltd. is a manufacturing company in China's flavor, fragrance, and food additive industries. Their products include edible flavors, cosmetics fragrances, spices, and food additives.
Reference:
1. Question and Answer Platform
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
